All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Fri 1980-03-28? to Fri 2026-01-16 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| GSK × |
−1.77%
2026-01-16 |
105.49 TRR
2026-01-16 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Fri 2026-01-16 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| GSK × |
+10,449.11%
+10.71%/yr |
+7.71%/yr
(R2=0.689) |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Fri 2026-01-16 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| GSK × |
$10,000.00
1980-03-28 |
$1,054,911.40
2026-01-16 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Year | GSK |
|---|---|
| 2026 (YTD) | −1.77% |
| 2025 | +47.28% |
| 2024 | −7.80% |
| 2023 | +6.17% |
| 2022 | −21.83% |
| 2021 | +18.43% |
| 2020 | −18.81% |
| 2019 | +26.36% |
| 2018 | +11.65% |
| 2017 | −5.00% |
| 2016 | +0.03% |
| 2015 | −0.97% |
| 2014 | −16.33% |
| 2013 | +27.04% |
| 2012 | −1.08% |
| 2011 | +19.08% |
| 2010 | −3.57% |
| 2009 | +16.15% |
| 2008 | −22.32% |
| 2007 | −4.69% |
| 2006 | +5.29% |
| 2005 | +6.23% |
| 2004 | +2.30% |
| 2003 | +26.35% |
| 2002 | −23.39% |
| 2001 | −11.03% |
| 2000 | +0.76% |
| 1999 | −20.07% |
| 1998 | +45.81% |
| 1997 | +53.26% |
| 1996 | +14.10% |
| 1995 | +41.71% |
| 1994 | +0.44% |
| 1993 | −12.83% |
| 1992 | −25.11% |
| 1991 | +93.04% |
| 1990 | +22.93% |
| 1989 | +32.55% |
| 1988 | +2.47% |
| 1987 | +15.85% |
| 1986 | +42.45% |
| 1985 | +80.35% |
| 1984 | +26.18% |
| 1983 | −5.44% |
| 1982 | +149.14% |
| 1981 | +15.73% |
| 1980 | +15.86% |
| Fri 1980-03-28? to Fri 2026-01-16 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| GSK × | −99.99% |
−100.00%
1985-09-30 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||